Ischemia-Modified Albumin and Atherosclerosis in Patients With Familial Mediterranean Fever

The constriction of vessels due to atherosclerotic lesions causes hypoxia/ischemia and oxidative changes resulting in transformation of free albumin to ischemia-modified albumin (IMA) in the circulation and increased carotid intima–media thickness (cIMT). We investigated the reliability of IMA increase in evaluating atherosclerosis in patients with familial Mediterranean fever (FMF) compared with cIMT. Patients with FMF (n = 58) diagnosed by the Tel-Hashomer criteria in attack-free period and 38 healthy people were included in the study. Patient demographics as well as the clinical and laboratory characteristics of the healthy controls and patients with FMF were noted. The IMA levels and cIMT in patients with FMF were 0.30 ± 0.09 absorbance units (ABSUs) and 1.12 ± 0.27 mm, respectively, and in the control group, IMA levels and cIMT were 0.25 ± 0.07 ABSU and 0.74 ± 0.26 mm, respectively. The IMA levels and cIMT were significantly higher in patients with FMF than in controls (P = .020 and P < .0001, respectively). The IMA values showed positive correlation with cIMT in patients with FMF(r = .302, P = .041). Our results reveal that IMA—an oxidative stress marker—may be an indicator of atherosclerosis in patients with FMF. This finding deserves further investigation.

[1]  T. Turker,et al.  Neutrophil–Lymphocyte Ratio and Carotid–Intima Media Thickness in Patients With Behçet Disease Without Cardiovascular Involvement , 2015, Angiology.

[2]  M. Karkucak,et al.  Ischemia-modified albumin (IMA): a novel marker of vascular involvement in Behçet's disease? , 2015, Joint, bone, spine : revue du rhumatisme.

[3]  S. Neşelioğlu,et al.  Comparison of serum oxidant and antioxidant parameters in familial Mediterranean fever patients (FMF) with attack free period. , 2014, Acta reumatologica portuguesa.

[4]  C. Ozturk,et al.  Endothelial Function and Behçet Disease , 2014, Angiology.

[5]  D. Mikhailidis,et al.  Bilirubin Levels and Their Association with Carotid Intima Media Thickness and High-Sensitivity C-reactive Protein in Patients with Psoriasis Vulgaris , 2014, American Journal of Clinical Dermatology.

[6]  E. Eren,et al.  Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure , 2014, Redox report : communications in free radical research.

[7]  O. Ali,et al.  Ischemic heart diseases in Egypt: role of xanthine oxidase system and ischemia-modified albumin , 2014, Heart and Vessels.

[8]  K. Deveci,et al.  Is Neutrophil/Lymphocyte Ratio Associated with Subclinical Inflammation and Amyloidosis in Patients with Familial Mediterranean Fever? , 2013, BioMed research international.

[9]  Y. Ozyazgan,et al.  Relation of protein oxidation parameters and disease activity in patients with Behçet's disease. , 2013, Clinical laboratory.

[10]  Haiying Xu,et al.  Ischemia-modified albumin in stable coronary atherosclerotic heart disease: clinical diagnosis and risk stratification , 2012, Coronary artery disease.

[11]  R. Manna,et al.  Familial Mediterranean fever: new phenotypes. , 2012, Autoimmunity reviews.

[12]  F. Yalçınkaya,et al.  Vascular comorbidities in familial Mediterranean fever , 2011, Rheumatology International.

[13]  I. Ben-Zvi,et al.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy , 2011, Nature Reviews Rheumatology.

[14]  A. Azazh,et al.  Diagnosis of ischemic heart disease using CK-MB, troponin-I and ischemia modified albumin. , 2011, Ethiopian medical journal.

[15]  A. Domínguez-Rodríguez,et al.  Current role of ischemia-modified albumin in routine clinical practice , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[16]  G. Kitas,et al.  The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. , 2010, Current vascular pharmacology.

[17]  A. Gasparyan,et al.  Open Access Familial Mediterranean Fever as an Emerging Clinical Model of Atherogenesis Associated with Low-Grade Inflammation , 2022 .

[18]  P. Langevitz,et al.  Familial Mediterranean Fever in Ashkenazi Jews: The Mild End of the Clinical Spectrum , 2010, The Journal of Rheumatology.

[19]  M. Dalamaga,et al.  Ischemia modified albumin, high-sensitivity c-reactive protein and natriuretic peptide in patients with coronary atherosclerosis. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[20]  H. Ozdogan,et al.  Intima-media thickening in patients with familial Mediterranean fever. , 2009, Rheumatology.

[21]  D. Gaze.  Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia. , 2009, Drug metabolism and pharmacokinetics.

[22]  A. Bakkaloğlu,et al.  Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis , 2008, Rheumatology International.

[23]  B. Oran,et al.  The evaluation of carotid intima-media thickness in children with familial Mediterranean fever , 2008, Clinical Rheumatology.

[24]  B. Reichman,et al.  A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever. , 2007, Seminars in arthritis and rheumatism.

[25]  A. Oto,et al.  Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. , 2006, Journal of the American College of Cardiology.

[26]  P O Collinson,et al.  Role of “Ischemia Modified Albumin”, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes , 2004, Emergency Medicine Journal.

[27]  E. Ben-Chetrit,et al.  Familial mediterranean fever - a review and update. , 2001, Minerva medica.

[28]  D. Bar-Or,et al.  A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. , 2000, The Journal of emergency medicine.

[29]  D. Zemer,et al.  Criteria for the diagnosis of familial Mediterranean fever. , 1997, Arthritis and rheumatism.

[30]  D. Mikhailidis,et al.  Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. , 1996, Platelets.

[31]  F. Fernández-Nogués,et al.  [Familial, mediterranean fever]. , 1977, Revista clinica espanola.